Healthcare provider profile · identity verified

David Robert Lawrence, MD

Internal Medicine · WINSTED, CT · NPI 1306852736

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	593	149
Rosuvastatin Calcium	Rosuvastatin Calcium	531	153
Omeprazole	Omeprazole	410	102
Levothyroxine Sodium	Levothyroxine Sodium	379	87
Amlodipine Besylate	Amlodipine Besylate	346	93
Lisinopril	Lisinopril	346	85
Metoprolol Succinate	Metoprolol Succinate	275	76
Losartan Potassium	Losartan Potassium	271	79
Hydrochlorothiazide	Hydrochlorothiazide	218	65
Gabapentin	Gabapentin	197	35
Simvastatin	Simvastatin	196	46
Eliquis	Apixaban	180	35
Pantoprazole Sodium	Pantoprazole Sodium	172	48
Warfarin Sodium	Warfarin Sodium	168	31
Tamsulosin Hcl	Tamsulosin Hcl	160	47
Furosemide	Furosemide	151	41
Allopurinol	Allopurinol	145	36
Metoprolol Tartrate	Metoprolol Tartrate	110	26
Mirtazapine	Mirtazapine	108	15
Pravastatin Sodium	Pravastatin Sodium	105	27
Metformin Hcl Er	Metformin Hcl	101	29
Potassium Chloride	Potassium Chloride	94	30
Finasteride	Finasteride	82	18
Glimepiride	Glimepiride	81	22
Duloxetine Hcl	Duloxetine Hcl	80	14
Escitalopram Oxalate	Escitalopram Oxalate	75	25
Metformin Hcl	Metformin Hcl	74	21
Fluticasone Propionate	Fluticasone Propionate	73	36
Doxazosin Mesylate	Doxazosin Mesylate	70	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	70	24
Albuterol Sulfate Hfa	Albuterol Sulfate	68	20
Atenolol	Atenolol	66	18
Jardiance	Empagliflozin	63	13
Torsemide	Torsemide	61	17
Carvedilol	Carvedilol	60	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	19
Citalopram Hbr	Citalopram Hydrobromide	55	17
Trazodone Hcl	Trazodone Hcl	53	14
Montelukast Sodium	Montelukast Sodium	51	18
Tramadol Hcl	Tramadol Hcl	51	19
Donepezil Hcl	Donepezil Hcl	47	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	46	suppressed
Prednisone	Prednisone	46	22
Ipratropium Bromide	Ipratropium Bromide	45	17
Buspirone Hcl	Buspirone Hcl	42	suppressed
Ezetimibe	Ezetimibe	42	15
Synthroid	Levothyroxine Sodium	41	12
Wixela Inhub	Fluticasone Propion/Salmeterol	40	12
Alendronate Sodium	Alendronate Sodium	39	11
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Spironolactone	Spironolactone	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Enalapril Maleate	Enalapril Maleate	35	suppressed
Sertraline Hcl	Sertraline Hcl	35	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	16
Famotidine	Famotidine	32	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	31	suppressed
Lovastatin	Lovastatin	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Ozempic	Semaglutide	26	suppressed
Tradjenta	Linagliptin	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	19
Triamcinolone Acetonide	Triamcinolone Acetonide	25	18
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Glipizide	Glipizide	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	11
Bupropion Xl	Bupropion Hcl	21	suppressed
Ketoconazole	Ketoconazole	21	12
Meloxicam	Meloxicam	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Nystatin	Nystatin	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	18	suppressed
Dofetilide	Dofetilide	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Valsartan	Valsartan	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Oxycontin	Oxycodone Hcl	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Digoxin	Digoxin	13	suppressed
Lithium Carbonate	Lithium Carbonate	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Xiidra	Lifitegrast	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error